(NASDAQ: SNY) Sanofi's forecast annual revenue growth rate of 7.66% is forecast to beat the US Drug Manufacturers - General industry's average forecast revenue growth rate of 2.8%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 9.2%.
Sanofi's revenue in 2023 is $42,463,636,363.On average, 3 Wall Street analysts forecast SNY's revenue for 2023 to be $59,926,728,818,875, with the lowest SNY revenue forecast at $59,627,808,265,259, and the highest SNY revenue forecast at $60,276,166,529,077. On average, 3 Wall Street analysts forecast SNY's revenue for 2024 to be $62,779,751,574,011, with the lowest SNY revenue forecast at $62,135,875,159,978, and the highest SNY revenue forecast at $63,887,738,885,561.
In 2025, SNY is forecast to generate $67,346,053,965,348 in revenue, with the lowest revenue forecast at $66,841,400,459,372 and the highest revenue forecast at $67,850,707,471,324.